Calcium Carbonate

Manufacturer: Preferred Pharmaceuticals Inc.
Effective date: 2018-04-03
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: legacy-cache
Hydrated at: 2026-08-02 01:00:23

Label at a glance#

ProductCalcium Carbonate (Antacid)

Active ingredientCALCIUM CARBONATE

Label structure8 sections

Indications and uses

for relief of • acid indigestion • heartburn • sour stomach • upset stomach associated with these symptoms

Storage and handling

• each tablet contains: calcium 260 mg • store at controlled room temperature 15 0 to 30 0 c (59 0 to 86 0 F) • use by expiration date on package

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Calcium carbonate 10 gr (648 mg, USP)

Purpose

OTC - PURPOSE SECTION

Antacid

Uses

INDICATIONS & USAGE SECTION

for relief of

acid indigestion
heartburn
sour stomach
upset stomach associated with these symptoms

Warnings

WARNINGS SECTION

Ask a doctor or pharmacist before use if

OTC - ASK DOCTOR/PHARMACIST SECTION

you are presently taking a prescription drug. Antacids may interact with certain prescription drugs.

If pregnant or nursing a baby,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of the reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Direction

DOSAGE & ADMINISTRATION SECTION

take one to four tablets daily
do not take more than 4 tablets in a 24 hour period
do not use the maximum dosage for more than 2 weeks

Other information

STORAGE AND HANDLING SECTION

each tablet contains: calcium 260 mg
store at controlled room temperature 15⁰ to 30⁰c (59⁰ to 86⁰F)
use by expiration date on package

Inactive ingredients

INACTIVE INGREDIENT SECTION

microcrystalline cellulose, croscarmellose sodium, stearic acid, magnesium stearate

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Product Linked Resources#

Resource, Code type, Value table
Resource	Code type	Value	Equivalent identifiers	Source image
Data code	Code 39			Calcium Carbonate 648 mg Tablet Package Label.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68788-6343-6	2020-11-09	C162847	48780-1	9d75b9d0-2434-f424-e053-dadaa90a57ce	Drug Facts
68788-6343-6	2020-01-31	C162847	48780-1	9d75b9d0-2434-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
16103-377-08	EA - Each	16103-377	629ba3f2-82bc-4623-85f1-cfe010b3a298	1	2022-06-06
16103-377-11	EA - Each	16103-377	6ccb1e2c-0f91-44f8-80f1-dc22040fcf6d	1	2022-06-06

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

Calcium Carbonate (Antacid)
Calcium Carbonate
CARBONATE ION
CALCIUM CATION
MICROCRYSTALLINE CELLULOSE
CROSCARMELLOSE SODIUM
STEARIC ACID
MAGNESIUM STEARATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68788-6343	68788-6343-6
16103-377

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CALCIUM CARBONATE	H0G9379FGK	ACTIB
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
STEARIC ACID	4ELV7Z65AP	IACT
MAGNESIUM STEARATE	70097M6I30	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
f52911a9-2a51-47c6-a7c2-43856122d444			d32d1d8b-2b12-4e0f-b343-f9d4e7cbfafb	2020-11-09	Warnings	Exact identifier spl set id: d32d1d8b-2b12-4e0f-b343-f9d4e7cbfafb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.